Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry.
dc.contributor.author | Dávila Fajardo, R | |
dc.contributor.author | Oldenburger, E | |
dc.contributor.author | Rübe, C | |
dc.contributor.author | López-Yurda, M | |
dc.contributor.author | Pritchard-Jones, K | |
dc.contributor.author | Bergeron, C | |
dc.contributor.author | Graf, N | |
dc.contributor.author | van Grotel, M | |
dc.contributor.author | van Tinteren, H | |
dc.contributor.author | Saunders, Daniel | |
dc.contributor.author | van den Heuvel-Eibrink, M | |
dc.contributor.author | Janssens, G | |
dc.contributor.author | Oldenburger, F | |
dc.date.accessioned | 2018-06-27T19:53:50Z | |
dc.date.available | 2018-06-27T19:53:50Z | |
dc.date.issued | 2018-04-25 | |
dc.identifier.citation | Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry. 2018, Pediatr Blood Cancer | en |
dc.identifier.issn | 1545-5017 | |
dc.identifier.pmid | 29693799 | |
dc.identifier.doi | 10.1002/pbc.27085 | |
dc.identifier.uri | http://hdl.handle.net/10541/621053 | |
dc.description.abstract | To evaluate the value of radiotherapy boost omission in patients with intermediate-risk, stage III Wilms tumours (WT) with positive lymph nodes (LN). | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Pediatric blood & cancer | en |
dc.title | Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry. | en |
dc.type | Article | en |
dc.contributor.department | Department of Radiation Oncology, University Medical Center Utrecht and Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands | en |
dc.identifier.journal | Pediatric Blood & Cancer | en |
html.description.abstract | To evaluate the value of radiotherapy boost omission in patients with intermediate-risk, stage III Wilms tumours (WT) with positive lymph nodes (LN). |